Executive Summary


Control of biomaterials distribution proposed in Russia

Shortage of drug storage equipment remains the main issue for distributors

New investment contract models for pharma

Federal Customs Service not equipped for drug marking

Roszdravnadzor director to implement digital health solutions


Roszdravnadzor proposed effective dates for marking different drug groups

Drug pricing changes to be made within the framework of existing procedure

Experts seek ways to implement online drug sales

Percentage of unapproved drugs being imported grows

MoH discussed public-private collaboration barriers


State Duma meets foreign pharmaceutical manufacturers

Pharma sees a growing number of intellectual property protection litigations

Drug advertising recommendations to be presented soon

It is time for pharma companies to market drugs via online pharmacies

A regular RAPM meeting discussed digitization of pharma reps


Boosting access to rare disease treatments

Pharmacies seeking new association format

MoH prevails over FAS in a drug interchangeability action

Doctors call for rethinking drug coverage approach for patients with psoriasis

Patients seek to contribute to development of National Oncology Program


AIPM pointed to biased attitude of Russian GMP Inspectorate to foreign manufacturers

Overall drug marking to become reality in a year

FAS attempts at sorting out generic price diminisher issue with pharma industry

Experts from different countries share best sterile manufacture practices

What’s wrong with medical waste disposal laws?


Russian government to protect intellectual property of pharma companies

Experts discussed contradictions and uncertainties of Russian manufacturer preferences

Localized drug manufacturers want better export terms

Experts advocate a no-hurry approach to approving online selling of Rx drugs

A new health investment concept


Results of GMP audits by Russian and foreign inspectorates often differ

Classical pharmacy chains skeptical about home drug delivery legalization

Next year, drug expenditures from all budget types may remain at 2017 level

EAEU common drug market: achievements and drawbacks

Russian pharma market traditionally demonstrates anomalous trends


Herman Klimenko urged doctors to keep up with new reality

Biocad to manufacture 22 antineoplastics in Moscow in 4 years

Growing patient numbers may cause budget gap in 2018

Pharma asks FAS for recommendations on advertising legislation execution

Large drug procurement discussed at Trade Exchange


New pharmacy regulations established once again

Who and why needs drug export?

Gelendzhik hosted Second All-Russia GMP Conference that attracted foreign participants

Experts discussed ways to decrease death rate in cancer

BioTechMed 2017 forum participants discussed market access of new drugs


Pharmacy chains complain about heavy fines for dispensing Rx drugs without prescription

Pharma companies hope to see their products on VED and other lists

Each flu vaccination campaign stirs public debate on benefits and safety

Has RIA Panda headed for premeditated bankruptcy?

Food retailers to put a lot of efforts before pharmacy project is implemented

Регистрируясь, вы принимаете условия
Пользовательского соглашения